Aging is a significant risk factor for cancer, with most diagnoses occurring in older adults. As we age, genetic mutations accumulate, and immune system efficiency declines, increasing cancer susceptibility. Cellular senescence, an aging hallmark, promotes a pro-inflammatory environment, contributing to tumor development.
For older patients, cancer treatment poses unique challenges. Comorbidities and reduced physiological reserves often limit the feasibility of aggressive therapies. Advances in geriatric oncology are now tailoring treatments to the specific needs of aging individuals, focusing on balancing efficacy and quality of life.
Studying the interplay between cancer and aging not only enhances understanding of disease progression but also drives innovations in early detection, prevention, and personalized care for an aging global population.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India